2-(2-((((Benzyloxy)carbonyl)(cyclopropyl)amino)methyl)pyrrolidin-1-yl)acetic acid

Catalog No.: 
ACCPNZ801
CAS No.: 
1353987-97-9
Molecular Formula: 
C18H24N2O4
Molecular Weight: 
332.40
2-(2-((((Benzyloxy)carbonyl)(cyclopropyl)amino)methyl)pyrrolidin-1-yl)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$1326.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-((((Benzyloxy)carbonyl)(cyclopropyl)amino)methyl)pyrrolidin-1-yl)acetic acid
IUPAC Name2-(2-((((benzyloxy)carbonyl)(cyclopropyl)amino)methyl)pyrrolidin-1-yl)acetic acid
MDL No.MFCD21095521
Molecular FormulaC18H24N2O4
Molecular Weight332.40
SMILESO=C(O)CN1C(CN(C(OCC2=CC=CC=C2)=O)C3CC3)CCC1
InChI KeyNVYCVUMILXBWFE-UHFFFAOYSA-N
Synonym{2-[(Benzyloxycarbonyl-cyclopropyl-amino)-methyl]-pyrrolidin-1-yl}-acetic acid;1-Pyrrolidineacetic acid, 2-[[cyclopropyl[(phenylmethoxy)carbonyl]amino]methyl]-
CAS No.1353987-97-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACCPNZ801 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCPNZ801 route product structure diagram
    ACCPNZ8011353987-97-9
Inquiry

2. ACCPNZ801 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCPNZ801 route product structure diagram
    ACCPNZ8011353987-97-9
Inquiry

3. ACCPNZ801 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCPNZ801 route product structure diagram
    ACCPNZ8011353987-97-9
Inquiry

Comments (0)